• Research
    • Our Mission
    • Multidrug Therapies
    • Surveillance
    • Stewardship
    • Education & Outreach
    • Publications
  • Resources & Services
    • Drug Combinations Lab
    • Levy CIMAR Summer Internship
    • AMR Pre-College Program
    • Educational Resources
    • For Levy CIMAR Faculty
    • Our Values
  • Publications
  • People
    • Leadership
    • Core Faculty
    • Affiliate Members
    • Featured Trainees
    • About Stuart B. Levy, M.D. 
  • News
    • Upcoming Events
    • Levy CIMAR in the News
    • Press Releases
  • Giving
  • Contact

Bacteriophages potentiate the effect of antibiotics by eradication of persister cells and killing of biofilm-forming cells

by Levy CIMAR | May 29, 2023 | Publications

Penicillium molds impact the transcriptome and evolution of the cheese bacterium Staphylococcus equorum

by Levy CIMAR | May 23, 2023 | Publications

Exploration of a Potential DOOR Endpoint for Complicated Intra-Abdominal Infections Using Nine Registrational Trials for Antibacterial Drugs

by Levy CIMAR | Apr 19, 2023 | Publications

Which trial do we need? Long-acting glycopeptides versus oral antibiotics for infective endocarditis in patients with substance use disorder

by Levy CIMAR | Apr 9, 2023 | Publications

Rachel Ende, PhD, Postdoctoral Scholar in the lab of CIMAR’s Dr. Joan Mecsas, studying mechanisms of synergistic antibiotic interactions against Klebsiella pneumoniae in the lungs

by Levy CIMAR | Mar 9, 2023 | Trainees

Page 50 of 86« First«...102030...4849505152...607080...»Last »

Recent Posts

  • EXPRESS: Factors associated with antimicrobial drug prescription in cats receiving outpatient care at a veterinary teaching hospital
  • Loss of essential outer membrane functions causes drug hypersensitization in Acinetobacter baumannii overexpressing multidrug efflux pumps
  • Growth arrest of Mycobacterium tuberculosis in acidic environments enhances their survival of antibiotic treatment
  • Point-Counterpoint: The “obsoletogram”—are annual hospital antibiograms still relevant?
  • Species-level reporting of Coagulase-negative staphylococci with MALDI-TOF does not impact clinical outcomes

The Levy CIMAR is a collaboration of Tufts Medical Center and the Tufts University Office of the Vice Provost for Research (OVPR) Research and Scholarship Strategic Plan (RSSP).

Contact us



South Cove 502, 136 Harrison Ave. Boston, MA. 02111



(617) 636-3824



CIMAR@tufts.edu

Join the CIMAR mailing list

Stay updated with our latest research, events and news.

© 2026 LevyCIMAR. All Rights Reserved.